# ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)

> **NCT00545610** · — · COMPLETED · sponsor: **Lisata Therapeutics, Inc.** · enrollment: 150 (estimated)

## Conditions studied

- Myocardial Ischemia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00545610
- **Lead sponsor:** Lisata Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2010-04
- **Final completion:** 2010-06
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2018-11-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00545610

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00545610, "ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00545610. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*